Catheter ablation has evolved into the dominant therapeutic modality i
n the treatment of a variety of arrhythmias, particularly supraventric
ular arrhythmias with the mechanisms of atrioventricular (AV) nodal re
entry and AV reciprocating tachycardia via an accessory pathway. The m
ode of catheter ablation used in the great majority of cases is radiof
requency (RF) catheter ablation. This technology is well-suited for th
e above arrhythmias because the targets and the RF lesions are both sm
all and discrete. Using temperature monitoring may improve the outcome
of these procedures by decreasing procedure time and incidence of coa
gulum formation on the catheter after a sudden rise in electrical impe
dance. New RF catheter designs and new modalities of creating catheter
-induced focal myocardial injury will allow operators to have improved
success with the ablation of less approachable arrhythmias, including
atrial flutter and reentrant ventricular tachycardia. Studies are cur
rently underway to create a catheter based ''maze'' procedure for the
treatment of atrial fibrillation. As techniques and technologies evolv
e, a greater proportion of patients with symptomatic or threatening ar
rhythmias may be approached with catheter ablation as a curative or pa
lliative procedure.